Chester County News and Community Website
GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed at tackling CMT2A, the most common axonal type of Charcot-Marie-Tooth disease. The …
CMTA Invests $300,000 in Groundbreaking Gene Editing Therapy for CMT2A Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $90,860 investment in a groundbreaking two-year research project at the University of California, San Diego (UC San Diego). Led by Dr. …
CMTA Funds Breakthrough Research at UC San Diego on CMT2A Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) announced this week an investment of $450,000 in cutting-edge research aimed at treating two common forms of the disorder, CMT1A and CMT1B. Spearheaded …
CMTA Injects $450K into Groundbreaking Research for Charcot-Marie-Tooth Disease Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has allocated over $200,000 to back the development of an innovative organoid model of CMT1A, the most prevalent form of this disease.
CMTA Invests $200,000 to Develop Innovative Organoid Model for Charcot-Marie-Tooth Disease Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a pioneering international research initiative, committing over $500,000 to two multiyear projects aimed at developing treatments for the most prevalent demyelinating …
New Research Initiative Targets Common Forms of Charcot-Marie-Tooth Disease Read More